2018-11-14T07:13:57-06:00 2017-12-31 410746749 CLIFTONLARSONALLEN LLP 901 N GLEBE ROAD SUITE 200 ARLINGTON VA 22203 990 2017-01-01 521006053 ADVANCED MEDICAL TECHNOLOGY ASSOCIATION ADVA 2027838700 701 PENNSYLVANIA AVENUE NW NO 800 WASHINGTON DC 200042654 JENNIFER BREAREY CHIEF FINANCIAL OFFICER 2027838700 2018-11-13 1 HEMALI PATEL P01337292 5712279500 67.137.57.251 2018-11-13 13:59:19 ES P 117C9FDD72C608EEAC637569487DFDD6D3A36660 3F26782FE4A8D097B8E6D44DA42E2066FBD559CC 2017 2019-02-21 02:37:17Z ADVAMED SCOTT WHITAKER 701 PENNSYLVANIA AVENUE NW NO 800 WASHINGTON DC 200042654 36202082 0 X WWW.ADVAMED.ORG X 1974 DE REPRESENT MEDICAL DIAGNOSTICS & DEVICE MANUFACTURERS ON REGULATORY & LEGISLATIVE ISSUES. 51 51 91 51 10248 7234 0 0 34201714 35244760 867895 896051 85668 61271 35155277 36202082 253900 284000 0 0 19081425 20278330 0 0 0 14866407 15361807 34201732 35924137 953545 277945 15577986 16551052 8329306 9302372 7248680 7248680 ADVAMED ADVOCATES ON A GLOBAL BASIS FOR THE HIGHEST ETHICAL STANDARDS, TIMELY PATIENT ACCESS TO SAFE AND EFFECTIVE MEDICAL TECHNOLOGIES, AND ECONOMIC POLICIES THAT REWARD VALUE CREATION. 0 0 ADVAMED'S GOVERNMENT AFFAIRS FUNCTION REPRESENTS THE INDUSTRY BEFORE STATE AND FEDERAL POLICYMAKERS, IN GOVERNOR'S OFFICES, STATE LEGISLATURES, THE UNITED STATES CONGRESS, AND RELEVANT FEDERAL AGENCIES. ADVAMED'S ADVOCACY STAFF AND OUTSIDE CONSULTANTS PROVIDE INFORMATION ON POLITICAL AND POLICY DEVELOPMENTS, AND PURSUE THE INDUSTRY'S AGENDA FOR A LEGAL, REGULATORY AND ECONOMIC ENVIRONMENT THAT ADVANCES HEALTH CARE BY ASSURING PATIENT ACCESS TO THE BENEFITS OF MEDICAL TECHNOLOGY. TAKING MEMBER COMPANY FEEDBACK FROM WORKING GROUPS AND COMMITTEES, ADVAMED STAFF PROVIDE CRITICAL INPUT TO REGULATORY AGENCIES LIKE FDA AND CMS ON REGULATIONS AND RULES THAT IMPACT THE ABILITY FOR PATIENTS TO RECEIVE TIMELY ACCESS TO LIFE CHANGING DEVICES PRODUCED BY ADVAMED MEMBERS. OUR CONSULTANTS IN JAPAN, CHINA, AND OTHER OVERSEAS MARKETS REPRESENT ADVAMED IN RAPIDLY EXPANDING OVERSEAS MARKETS AND ATTEND MEETINGS WITH GOVERNMENT OFFICIALS AND INDUSTRY COMMITTEE MEETINGS. THESE CONSULTANTS PROVIDE REAL-TIME INFORMATION AND AN INDUSTRY VOICE IN OVERSEAS MARKETS. 0 0 1 1 0 0 0 0 0 1 0 0 0 1 1 0 1 0 1 1 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 1 72 0 91 1 1 1 1 JA CH 0 0 0 0 X 51 51 0 0 1 0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 X JENNIFER BREAREY 2027838700 701 PENNSYLVANIA AVENUE NW SUITE WASHINGTON DC 200042654 PETER ARDUINI SECRETARY 1.00 X X 0 0 0 LESTER KNIGHT TREASURER 1.00 X X 0 0 0 NADIM YARED CHAIRPERSON 1.00 X X 0 0 0 ROBERT ABERNATHY DIRECTOR 1.00 X 0 0 0 ABIA NACHO DIRECTOR 1.00 X 0 0 0 MICHAEL F BALL DIRECTOR 1.00 X 0 0 0 ANDRE-MICHEL BALLESTER DIRECTOR 1.00 X 0 0 0 BRIAN BLASER DIRECTOR 1.00 X 0 0 0 SCOTT BROOKS DIRECTOR 1.00 X 0 0 0 ANN BUNNENBERG DIRECTOR 1.00 X 0 0 0 DONALD CASEY DIRECTOR 1.00 X 0 0 0 JAMES CLEMMER DIRECTOR 1.00 X 0 0 0 PATRICK DALY DIRECTOR 1.00 X 0 0 0 TIMOTHY DUGAN DIRECTOR 1.00 X 0 0 0 DENNIS DURMIS DIRECTOR 1.00 X 0 0 0 DAVID DVORAK DIRECTOR 1.00 X 0 0 0 LISA EARNHARDT DIRECTOR 1.00 X 0 0 0 ANDREW R ECKERT DIRECTOR 1.00 X 0 0 0 BRIK EYRE DIRECTOR 1.00 X 0 0 0 CAMILLE FARHAT DIRECTOR 1.00 X 0 0 0 MICHAEL FARRELL DIRECTOR 1.00 X 0 0 0 VINCENT FORLENZA DIRECTOR 1.00 X 0 0 0 TODD FRUCHTERMAN DIRECTOR 1.00 X 0 0 0 MICHAEL GENAU DIRECTOR 1.00 X 0 0 0 JOHN GREISCH DIRECTOR 1.00 X 0 0 0 CHRIS HOLMES DIRECTOR 1.00 X 0 0 0 STEFFEN HOVARD DIRECTOR 1.00 X 0 0 0 JOHN KILCOYNE DIRECTOR 1.00 X 0 0 0 KEVIN LOBO DIRECTOR 1.00 X 0 0 0 STEPHEN MACMILLAN DIRECTOR 1.00 X 0 0 0 GEORGE V MALIEKEL DIRECTOR 1.00 X 0 0 0 JEFFERY MCCAULLEY DIRECTOR 1.00 X 0 0 0 DAMIEN MCDONALD DIRECTOR 1.00 X 0 0 0 MICHAEL MINOGUE DIRECTOR 1.00 X 0 0 0 MICHAEL MUSSALLEM DIRECTOR 1.00 X 0 0 0 CAROLL NEUBAUER DIRECTOR 1.00 X 0 0 0 DAVID PACITTI DIRECTOR 1.00 X 0 0 0 DAVID PEREZ DIRECTOR 1.00 X 0 0 0 MICHAEL PHALEN DIRECTOR 1.00 X 0 0 0 JACK PHILLIPS DIRECTOR 1.00 X 0 0 0 GARY PRUDEN DIRECTOR 1.00 X 0 0 0 TIMOTHY RING DIRECTOR 1.00 X 0 0 0 WALTER ROSEBROUGH DIRECTOR 1.00 X 0 0 0 SCOTT SCHORER DIRECTOR 1.00 X 0 0 0 MARTHA SHADAN DIRECTOR 1.00 X 0 0 0 BRENT SHAFER DIRECTOR 1.00 X 0 0 0 BRADY SHIRLEY DIRECTOR 1.00 X 0 0 0 BENSON SMITH DIRECTOR 1.00 X 0 0 0 GLENN WARNER DIRECTOR 1.00 X 0 0 0 DOW WILSON DIRECTOR 1.00 X 0 0 0 JOSEPH WOODY DIRECTOR 1.00 X 0 0 0 JENNIFER BREAREY CHIEF FINANCIAL OFFICER 40.00 X 303753 0 49436 SCOTT WHITAKER CHIEF EXECUTIVE OFFICER 40.00 X 1227435 0 49175 CHRISTOPHER L WHITE EXEC VP, GEN COUNSEL 40.00 X 690135 0 49881 RALPH IVES EXEC VP, GLOBAL STRATEGY 40.00 X 481009 0 32474 ANDREW FISH CHIEF STRATEGY OFFICER 40.00 X 688451 0 47359 DONALD MAY EVP, PMT & HEALTH CARE DELIV POLICY 40.00 X 482197 0 42361 JUAN CARLOS SCOTT CHIEF ADVOCACY OFFICER 40.00 X 642453 0 49776 STEVEN BROTMAN SVP, PMT & HEALTH CARE DELIV POLICY 40.00 X 397420 0 44483 GREG CRIST EVP, PUBLIC AFFAIRS 40.00 X 353738 0 8701 KENNETH MENDEZ CHIEF REVENUE OFFICER 40.00 X 541797 0 49620 ELIZABETH PIKA SHARP SVP AND MANAGING DIRECTOR, FEDERAL GOVERNMENT AFFA 40.00 X 357441 0 49619 JANET TRUNZO EVP, TECH & REGULATORY AFFAIRS 40.00 X 546053 0 38059 6711882 0 510944 48 0 1 0 STORY PARTNERS LLC 1000 POTOMAC STREET NW SUITE 102 WASHINGTON DC 20007 PUBLIC AFFAIRS SVC 612350 BGR GOVERNMENT AFFAIRS LLC PO BOX 14416 601 13TH ST NW WASHINGTON DC 200444416 GOVERNMENT AFFAIRS SVC 288577 TARPLIN DOWNS & YOUNG LLC 1212 NEW YORK AVE NW STE 1050 WASHINGTON DC 20005 GOVERNMENT AFFAIRS SVC 247500 REED SMITH LLP PO BOX 759052 BALTIMORE MD 21275 LEGAL SERVICES 238621 DYNAMIC STRATEGIES ASIA LC 5335 WISCONSIN AVE STE 440 WASHINGTON DC 20015 JAPAN POLITICAL ADVOCACY 225000 32 MEMBERSHIP DUES 900099 32723890 32723890 SEMINARS 611430 2247307 2247307 SPECIAL PROJECTS 900099 273563 273563 35244760 896051 896051 51023 51023 JOB BOARD REVENUE 900099 10248 10248 10248 36202082 35244760 10248 947074 X 284000 4817337 12733668 921136 1048680 757509 617079 44502 3510158 3978805 9192 856586 136257 1869501 1384704 1938462 356001 89019 DUES AND SUBSCRIPTIONS 439882 TRAINING 11835 119824 35924137 516 352 12788093 11734212 547165 1700435 239972 529850 6603099 5622901 609494 980198 1385909 1591825 1837 5000 14180 15577986 16551052 3966978 4494042 2245852 1530749 2116476 3277581 8329306 9302372 X 7248680 7248680 7248680 7248680 15577986 16551052 X 277945 -277945 X 0 1 X 1 0 10000 5000 5000 10000 1 ADVAMED CALIFORNIA PAC 701 PENNSYLVANIA AVENUE NW WASHINGTON DC 20004 455309081 5000 NYS SENATE REPUBLICAN CAMPAIGN COMMITTEE 152 WASHINGTON AVENUE SUITE 200 ALBANY ME 12210 141753654 5000 0 0 1 30288574 3510158 739177 4249335 4337693 -88358 PART I-A, LINE 1: ADVAMED PROVIDED $5,000 OF FUNDING TO ADVAMED'S CALIFORNIA PAC AND PROVIDED $5,000 TO NYS SENATE REPUBLICAN CAMPAIGN COMMITTEE. 3170085 2601081 569004 870187 787542 82645 2562827 2234278 328549 980198 DEFERRED RENT 768878 DEFERRED COMPENSATION 1591825 DEFERRED TENANT ALLOWANCE 574684 DEFERRED ASSESSMENTS 342194 3277581 X 36399097 197015 197015 36202082 0 36202082 36405842 481705 481705 35924137 0 35924137 PART X, LINE 2: ADVAMED COMPLIES WITH THE ACCOUNTING STANDARD ON ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES. MANAGEMENT EVALUATED ADVAMED'S TAX POSITIONS AND CONCLUDED THAT IT HAD TAKEN NO UNCERTAIN TAX POSITIONS THAT REQUIRE ADJUSTMENT TO THE CONSOLIDATED FINANCIAL STATEMENTS TO COMPLY WITH THE PROVISIONS OF THIS GUIDANCE. PART XI, LINE 2D - OTHER ADJUSTMENTS: ADVAMED PAC REVENUE 165,534. ADVAMED CA PAC REVENUE 22,300. ADVAMED PURCHASING GROUP 9,181. PART XII, LINE 2D - OTHER ADJUSTMENTS: ADVAMED PAC EXPENSES 165,279. ADVAMED CA PAC EXPENSES 29,300. ADVAMED PURCHASING GROUP 287,126. EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA, 2 10 PROGRAM SERVICES CONSULTANT IN ASIA MEET WITH GOVERNMENT AND INDUSTRY OFFICIALS 1597272 EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA, 0 0 PROGRAM SERVICES STAFF TRAVEL TO REGION FOR MEETINGS 224574 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM 0 5 PROGRAM SERVICES CONSULTANT IN EUROPE MEET WITH GOVERNMENT AND INDUSTRY OFFICIALS 297388 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM 0 0 PROGRAM SERVICES STAFF TRAVEL TO REGION FOR MEETINGS 195447 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM 0 3 PROGRAM SERVICES MEETINGS TO PROMOTE THE HARMONIZATION OF INTERNATIONAL STANDARDS 437222 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM 0 0 PROGRAM SERVICES STAFF TRAVEL FOR 2017 MEETINGS TO PROMOTE THE HARMONIZATION OF INTL STANDARDS 20582 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM 0 0 PROGRAM SERVICES PREPAYMENTS FOR 2018 MEETINGS TO PROMOTE THE HARMONIZATION OF INTL STANDARDS (STAFF TRAVEL) 3989 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM 0 0 PROGRAM SERVICES PREPAYMENTS FOR 2018 MEETINGS TO PROMOTE THE HARMONIZATION OF INTL STANDARDS 55861 CENTRAL AMERICA AND THE CARIBBEAN 0 0 PROGRAM SERVICES STAFF TRAVEL TO REGION FOR MEETINGS 2700 NORTH AMERICA - MEXICO AND CANADA 0 0 PROGRAM SERVICES CONSULTANT IN NORTH AMERICA MEET WITH GOVERNMENT AND INDUSTRY OFFICIALS 57450 NORTH AMERICA - MEXICO AND CANADA 0 0 PROGRAM SERVICES STAFF TRAVEL TO REGION FOR MEETINGS 7978 SOUTH AMERICA - ARGENTINA, BOLIVIA, BRAZIL, CHILE, COLUMBIA, ECUADOR, 0 2 PROGRAM SERVICES CONSULTANT IN SOUTH AMERICA MEET WITH GOVERNMENT AND INDUSTRY OFFICIALS 398688 SOUTH AMERICA - ARGENTINA, BOLIVIA, BRAZIL, CHILE, COLUMBIA, ECUADOR, 0 0 PROGRAM SERVICES STAFF TRAVEL TO REGION FOR MEETINGS 19873 SOUTH AMERICA - ARGENTINA, BOLIVIA, BRAZIL, CHILE, COLUMBIA, ECUADOR, 0 0 PROGRAM SERVICES MEETINGS TO PROMOTE THE HARMONIZATION OF INTERNATIONAL STANDARDS 104282 SOUTH AMERICA - ARGENTINA, BOLIVIA, BRAZIL, CHILE, COLUMBIA, ECUADOR, 0 0 PROGRAM SERVICES STAFF TRAVEL FOR 2017 MEETINGS TO PROMOTE THE HARMONIZATION OF INTL STANDARDS 12867 SOUTH ASIA - AFGHANISTAN, BANGLADESH, BHUTAN, INDIA, MALDIVES, NEPAL, 0 2 PROGRAM SERVICES CONSULTANTS IN SOUTH ASIA MEET WITH GOVERNMENT AND INDUSTRY OFFICIALS 451068 SOUTH ASIA - AFGHANISTAN, BANGLADESH, BHUTAN, INDIA, MALDIVES, NEPAL, 0 0 PROGRAM SERVICES STAFF TRAVEL TO REGION FOR MEETINGS 12497 2 18 0 4 2 22 2832335 1067403 3899738 0 0 0 0 0 0 1 RESEARCH AMERICA 1101 KING STREET SUITE 520 ALEXANDRIA VA 22314 521609875 501(C)(3) 52000 PROGRAM SUPPORT ALLIANCE FOR AGING RESEARCH 750 17TH STREET NW SUITE 1100 WASHINGTON DC 20006 541379174 501(C)(3) 30000 PROGRAM SUPPORT UNITED SPINAL ASSOCIATION 75-20 ASTORIA BOULEVARD SUITE 120 JACKSON HEIGHTS NY 11370 135612621 501(C)(3) 30000 PROGRAM SUPPORT JUVENILE DIABETES RESEARCH FOUNDATION (JDRF) 1400 K STREET NW SUITE 725 WASHINGTON DC 20005 510150028 501(C)(3) 20000 PROGRAM SUPPORT SOCIETY FOR WOMEN'S HEALTH RESEARCH 1025 CONNECTICUT AVENUE NW SUITE 601 WASHINGTON DC 20036 521694732 501(C)(3) 15000 PROGRAM SUPPORT NATIONAL HEALTH COUNCIL 1730 M STREET NW SUITE 500 WASHINGTON DC 20036 131624107 501(C)(3) 9100 PROGRAM SUPPORT AIDS INSTITUTE INC 17 DAVIS BOULEVARD SUITE 403 TAMPA FL 33606 650380952 501(C)(3) 10000 PROGRAM SUPPORT LUNGEVITY FOUNDATION 228 SOUTH WABASH AVENUE SUITE 700 CHICAGO IL 60604 364433410 501(C)(3) 10000 PROGRAM SUPPORT PREVENT CANCER FOUNDATION 1600 DUKE STREET SUITE 500 ALEXANDRIA VA 22314 521429544 501(C)(3) 10000 PROGRAM SUPPORT SPINA BIFIDA-ASSOCIATION OF AMERICA 4590 MACARTHUR BOULEVARD NW SUITE 250 WASHINGTON DC 20007 581342181 501(C)(3) 10000 PROGRAM SUPPORT DAVID A WINSTON HEALTH POLICY 2000 14TH STREET NORTH SUITE 780 ARLINGTON VA 22201 521492039 501(C)(3) 5500 PROGRAM SUPPORT AMERICARES 88 HAMILTON AVENUE STAMFORD CT 06902 061008595 501(C)(3) 5200 PROGRAM SUPPORT 12 PART I LINE 2: ADVAMED BUDGETS ANNUALLY FOR CHARITABLE DONATIONS AND OTHER CHARITABLE GIVING THAT IS CLOSELY ALIGNED WITH ITS STRATEGIC PLAN AND MISSION. IN ADDITION, ADVAMED MAY IDENTIFY CAUSES THROUGHOUT THE YEAR THAT MAY REQUIRE REPURPOSING OF FUNDS FROM ANOTHER EXPENSE CATEGORY TO SUPPORT CERTAIN MEDICAL DEVICE ISSUES OR MEMBERSHIP INITIATIVES, ALL SUCH SPENDING IS PROCESSED THROUGH ADVAMED'S PURCHASE ORDER SYSTEM, WHICH REQUIRES SEVERAL LEVELS OF EXECUTIVE APPROVAL BEFORE ANY FUNDING IS MADE. X X 1 1 X X X X X 0 0 0 JENNIFER BREAREY CHIEF FINANCIAL OFFICER 264929 0 38308 0 516 0 31172 0 18264 0 353189 0 0 0 SCOTT WHITAKER CHIEF EXECUTIVE OFFICER 942827 0 277500 0 7108 0 31284 0 17891 0 1276610 0 0 0 CHRISTOPHER L WHITE EXEC VP, GEN COUNSEL 570081 0 118812 0 1242 0 31545 0 18336 0 740016 0 0 0 RALPH IVES EXEC VP, GLOBAL STRATEGY 403734 0 70417 0 6858 0 31284 0 1190 0 513483 0 0 0 ANDREW FISH CHIEF STRATEGY OFFICER 575107 0 112132 0 1212 0 29745 0 17614 0 735810 0 0 0 DONALD MAY EVP, PMT & HEALTH CARE DELIV POLICY 405286 0 76101 0 810 0 31284 0 11077 0 524558 0 0 0 JUAN CARLOS SCOTT CHIEF ADVOCACY OFFICER 529410 0 112233 0 810 0 31440 0 18336 0 692229 0 0 0 STEVEN BROTMAN SVP, PMT & HEALTH CARE DELIV POLICY 336268 0 58830 0 2322 0 31284 0 13199 0 441903 0 0 0 GREG CRIST EVP, PUBLIC AFFAIRS 352928 0 0 0 810 0 0 0 8701 0 362439 0 0 0 KENNETH MENDEZ CHIEF REVENUE OFFICER 458425 0 81050 0 2322 0 31284 0 18336 0 591417 0 0 0 ELIZABETH PIKA SHARP SVP AND MANAGING DIRECTOR, FEDERAL G 298521 0 58380 0 540 0 31284 0 18335 0 407060 0 0 0 JANET TRUNZO EVP, TECH & REGULATORY AFFAIRS 446708 0 88221 0 11124 0 31284 0 6775 0 584112 0 0 0 PART I, LINE 1A FIRST CLASS TRAVEL IS AUTHORIZED ONLY IN EXCEPTIONAL CIRCUMSTANCES, SUCH AS WHEN IT IS NECESSARY TO TAKE A SPECIFIC FLIGHT WHERE BUSINESS OR COACH CLASS IS NOT AVAILABLE, AND MUST FIRST HAVE PRIOR WRITTEN APPROVAL BY DEPARTMENT HEADS AND ADVAMED'S PRESIDENT. OTHER EXPENSES INCURRED BY THE TRAVELER FOR TRAVEL OUTSIDE THE DEFINITION OF A BUSINESS TRIP, INCLUDING EXPENSES FOR FAMILY MEMBERS TRAVELING WITH THE EMPLOYEE, ARE ALSO THE RESPONSIBILITY OF THE TRAVELER AND NOT ADVAMED. SUCH EXPENSES ARE KEPT SEPARATE FROM REIMBURSABLE BUSINESS EXPENDITURES. PERSONAL TRAVEL FOR FAMILY MEMBERS/FRIENDS MAY BE BOOKED THROUGH ADVAMED'S TRAVEL AGENCY BUT ARE IDENTIFIED SEPARATELY AND BILLED DIRECTLY TO THE EMPLOYEE. THE CEO OF ADVAMED MAY TRAVEL BUSINESS CLASS ON ALL INTERNATIONAL FLIGHTS AND FOR TRAVEL OVER THREE HOURS IN DURATION WHERE SUCH SEATING IS AVAILABLE. FIRST CLASS SEATING WILL BE REIMBURSED ON DOMESTIC FLIGHTS OVER THREE (3) HOURS IN DURATION IF BUSINESS CLASS SEATING IS NOT OFFERED ON THE FLIGHT. THE ASSOCIATION SHALL REIMBURSE TRAVEL EXPENSES FOR EXECUTIVE'S SPOUSE TO ASSOCIATION EVENTS WHEN ATTENDANCE IS REQUIRED FOR BUSINESS PURPOSES. TRAVEL IS NOT INCLUDED IN TAXABLE INCOME. FORM 990, PART VI, SECTION A, LINE 1 THERE SHALL BE AN EXECUTIVE COMMITTEE, WHICH SHALL CONSIST OF THE PRESIDENT, ELECTED OFFICERS OF THE ASSOCIATION, THE IMMEDIATE PAST CHAIRMAN, THE ADVAMED-DX CHAIRMAN, AND NOT FEWER THAN FIVE NOR MORE THAN TEN MEMBERS OF THE BOARD OF DIRECTORS AT LARGE, WHO SHALL BE ELECTED TO THAT POSITION, FOR A PERIOD OF ONE YEAR AND THEREAFTER UNTIL A SUCCESSOR SHALL HAVE BEEN DULY ELECTED AND QUALIFIED, BY A MAJORITY OF THE ENTIRE BOARD OF DIRECTORS ANNUALLY. THE EXECUTIVE COMMITTEE SHALL PERFORM SUCH DUTIES AS MAY BE DELEGATED TO IT BY THE BOARD OF DIRECTORS, AND MAY FURTHER ACT FOR AND ON BEHALF OF THE BOARD OF DIRECTORS BETWEEN MEETINGS OF THE BOARD OF DIRECTORS, PROVIDED THAT ALL SUCH ACTS SHALL BE FULLY REPORTED TO THE BOARD OF DIRECTORS AT OR BEFORE ITS NEXT MEETING FOR ITS REVIEW AND APPROPRIATE ACTION, IF REQUIRED OR DEEMED NECESSARY. FORM 990, PART VI, SECTION A, LINE 4 THE ORGANIZATION UPDATED THE NUMBER OF BOARD MEMBERS FROM 50 TO 60 IN 2017 ON ITS GOVERNING DOCUMENTS. FORM 990, PART VI, SECTION A, LINE 6 ANY FIRM OR CORPORATION WHICH, THROUGH ITSELF OR THROUGH ANY OF ITS SUBSIDIARIES OR DIVISIONS, IS SIGNIFICANTLY ENGAGED IN THE MANUFACTURE OF AND/OR THE RESEARCH WITH THE INTENT TO MANUFACTURE MEDICAL DEVICES, DIAGNOSTIC PRODUCTS AND/OR HEALTH CARE INFORMATION SYSTEMS WITHIN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS, SHALL BE ELIGIBLE FOR ACTIVE MEMBERSHIP. FORM 990, PART VI, SECTION A, LINE 7A EACH ACTIVE MEMBER IN GOOD STANDING SHALL BE ENTITLED TO ONE VOTE ON ANY QUESTION COMING BEFORE THE GENERAL MEMBERSHIP, INCLUDING THE ELECTION OF ONE THIRD OF THE BOARD OF DIRECTORS ANNUALLY. THE BOARD NOMINATING AND GOVERNANCE COMMITTEE PRESENTS A PROPOSED SLATE OF DIRECTORS ANNUALLY TO THE MEMBERSHIP FOR VOTE. EACH ACTIVE MEMBER SHALL, IN WRITING, DESIGNATE ITS OFFICIAL REPRESENTATIVE TO VOTE AND REPRESENT THAT MEMBER IN ALL OF THE AFFAIRS OF THE ASSOCIATION, INCLUDING THE HOLDING OF OFFICE. FORM 990, PART VI, SECTION A, LINE 7B EACH ACTIVE MEMBER IN GOOD STANDING SHALL BE ENTITLED TO ONE VOTE ON ANY QUESTION COMING BEFORE THE GENERAL MEMBERSHIP. EACH ACTIVE MEMBER SHALL, IN WRITING, DESIGNATE ITS OFFICIAL REPRESENTATIVE TO VOTE AND REPRESENT THAT MEMBER IN ALL OF THE AFFAIRS OF THE ASSOCIATION, INCLUDING THE HOLDING OF OFFICE. SUCH OFFICIAL REPRESENTATIVE SHALL BE THE CHIEF EXECUTIVE OFFICER OR CHIEF OPERATING OFFICER OF THE MEMBER OR SUCH OTHER SENIOR OPERATING OFFICER AS THE CHIEF EXECUTIVE OFFICER MAY DESIGNATE. FORM 990, PART VI, SECTION B, LINE 11B ADVAMED'S CHIEF FINANCIAL OFFICER AND CONTROLLER PERFORM AN INDEPTH REVIEW OF THE DRAFT 990. THE GENERAL COUNSEL REVIEWS THE FINAL DRAFT PRIOR TO SUBMITTING TO THE FINANCE AND AUDIT COMMITTEE (FAC). UPON THE FAC'S REVIEW THE 990 IS SUBMITTED TO THE FULL BOARD FOR THEIR REVIEW. PROVIDED NO CONCERNS ARE RAISED PRIOR TO THE END OF THE REVIEW PERIOD, THE 990 IS THEN FINALIZED AND SUBMITTED TO THE IRS. FORM 990, PART VI, SECTION B, LINE 12C ADVAMED HAS IN PLACE A CONFLICT OF INTEREST POLICY THAT IS MONITORED REGULARLY. EXCERPTS FROM THE POLICY RELATED TO THIS QUESTION ARE SHOWN BELOW: THE CONFLICT OF INTEREST POLICY OF ADVAMED: (1) DEFINES CONFLICTS OF INTEREST; (2) IDENTIFIES CLASSES OF INDIVIDUALS WITHIN THE ASSOCIATION COVERED BY THIS POLICY; (3) FACILITATES DISCLOSURE OF INFORMATION THAT MAY HELP IDENTIFY CONFLICTS OF INTEREST; AND (4) SPECIFIES PROCEDURES TO BE FOLLOWED IN MANAGING CONFLICTS OF INTEREST. 1. A CONFLICT OF INTEREST ARISES WHEN A PERSON IN A POSITION OF AUTHORITY OVER THE ASSOCIATION MAY BENEFIT FINANCIALLY FROM A DECISION HE OR SHE COULD MAKE IN THAT CAPACITY, INCLUDING INDIRECT BENEFITS SUCH AS TO FAMILY MEMBERS OR BUSINESSES WITH WHICH THE PERSON IS CLOSELY ASSOCIATED. ADVAMED'S POLICY IS FOCUSED UPON MATERIAL FINANCIAL INTEREST OF, OR BENEFIT TO, SUCH PERSONS. 2. PERSONS COVERED BY THIS POLICY ARE THE ASSOCIATION'S STAFF, OFFICERS, DIRECTORS, CHIEF EXECUTIVE OFFICER, AND CHIEF ADMINISTRATIVE OFFICER. 3. PERSONS COVERED BY THIS POLICY ANNUALLY DISCLOSE TO THE GENERAL COUNSEL ON A FORM PROVIDED BY THE ASSOCIATION THEIR INTERESTS THAT COULD GIVE RISE TO CONFLICTS OF INTEREST, SUBSTANTIAL BUSINESS OR INVESTMENT HOLDINGS, AND OTHER TRANSACTIONS OR AFFILIATIONS WITH BUSINESSES AND OTHER ORGANIZATIONS OR THOSE OF FAMILY MEMBERS. 4. FOR EACH INTEREST DISCLOSED TO THE GENERAL COUNSEL, THE GENERAL COUNSEL WILL DETERMINE WHETHER TO: (A) TAKE NO ACTION; (B) ASSURE FULL DISCLOSURE TO THE BOARD OF DIRECTORS AND OTHER INDIVIDUALS COVERED BY THIS POLICY; (C) ASK THE PERSON TO RECUSE FROM PARTICIPATION IN RELATED DISCUSSIONS OR DECISIONS WITHIN THE ASSOCIATION; OR (D) ASK THE PERSON TO RESIGN FROM HIS OR HER POSITION IN THE ASSOCIATION OR, IF THE PERSON REFUSES TO RESIGN, BECOME SUBJECT TO POSSIBLE REMOVAL IN ACCORDANCE WITH THE ASSOCIATION'S REMOVAL PROCEDURES. THE ASSOCIATION'S CHIEF OPERATING OFFICER AND CHIEF FINANCIAL OFFICER WILL MONITOR PROPOSED OR ONGOING TRANSACTIONS FOR CONFLICTS OF INTEREST AND DISCLOSE THEM TO THE CHAIRMAN OF THE BOARD OF DIRECTORS IN ORDER TO DEAL WITH POTENTIAL OR ACTUAL CONFLICTS, WHETHER DISCOVERED BEFORE OR AFTER THE TRANSACTION HAS OCCURRED. INTERESTS IN MEMBER COMPANIES: AT TIMES, ADVAMED STAFF AND/OR DIRECTORS MAY BE AWARE OF THE SIGNIFICANT AMOUNT OF INTEREST GENERATED IN CONNECTION WITH NEW PRODUCT DEVELOPMENT, SALES AND PROFITS, PRODUCT REGULATORY STATUS, AND ACQUISITIONS IN THE HEALTH CARE TECHNOLOGY INDUSTRY, THUS, ANYONE IN POSSESSION OF MATERIAL INFORMATION NOT GENERALLY AVAILABLE TO THE INVESTING PUBLIC MUST, IN ORDER TO COMPLY WITH THIS POLICY, EITHER DISCLOSE THAT KNOWLEDGE OR REFRAIN FROM TRADING IN THE STOCK. IN ADDITION, THE PURCHASE OF STOCK IN MEMBER COMPANIES CAN LEAD TO THE APPEARANCE THAT A MEMBER OF THE STAFF AND/OR BOARD OF DIRECTORS IS FAVORING THE INTERESTS OF THAT COMPANY BECAUSE OF SUCH FINANCIAL INTEREST. EVEN IF THERE IS NO ACTUAL CONFLICT OF INTEREST, THE APPEARANCE OF IMPROPRIETY MUST BE AVOIDED. NO EMPLOYEE OF THE ASSOCIATION OR MEMBER OF ITS BOARD OF DIRECTORS, EITHER IN HIS OR HER OWN NAME, OR IN THE NAME OF HIS OR HER SPOUSE OR CHILDREN, MAY PURCHASE STOCK IN ANY MEMBER COMPANY WITHOUT ADVISING THE ASSOCIATION PRESIDENT OF SUCH OWNERSHIP OR CONTEMPLATED OWNERSHIP. IN 2010, ADVAMED REQUIRED EMPLOYEES AND DIRECTORS TO SUBMIT AN ANNUAL FINANCIAL DISCLOSURE STATEMENT TO THE GENERAL COUNSEL REGARDING HOLDINGS IN MEMBER COMPANIES. AFTER REVIEW OF THE COMPLETED FORMS BY THE GENERAL COUNSEL, POTENTIAL CONFLICTS ARE REPORTED TO THE PRESIDENT, WHO REPORTS ANY SUCH DISCLOSURES TO THE CHAIRMAN OF THE BOARD OF DIRECTORS. INTEREST IN ENTITIES DOING BUSINESS WITH ADVAMED: IN THE COURSE OF ITS DAY-TO-DAY OPERATIONS, ADVAMED CONTRACTS WITH NUMEROUS FIRMS THAT PROVIDE GOODS AND SERVICES. IT IS IMPORTANT THAT THESE FIRMS ARE CHOSEN FOR BUSINESS PURPOSES AND NOT BECAUSE THEY ARE INAPPROPRIATELY FAVORED BY ADVAMED EMPLOYEES OR DIRECTORS WHO MAY HAVE A FINANCIAL INTEREST IN PARTICULAR TRANSACTIONS. ACCORDINGLY, ADVAMED EMPLOYEES AND DIRECTORS MUST DISCLOSE, ON AN ONGOING BASIS, ANY FINANCIAL INTEREST IN A COMPANY WITH WHICH ADVAMED CONTRACTS, OR IS CONSIDERING. FORM 990, PART VI, SECTION B, LINE 15 THE PROCESS INCLUDES ALL OF THESE ELEMENTS: (1) REVIEW AND APPROVAL BY THE BOARD COMMITTEE ON FINANCE, AUDIT AND COMPENSATION OF THE ASSOCIATION; (2) USE OF DATA AS TO COMPARABLE COMPENSATION; AND (3) CONTEMPORANEOUS DOCUMENTATION AND RECORDKEEPING. 1. REVIEW AND APPROVAL: THE COMPENSATION OF THE PERSON IS REVIEWED AND APPROVED BY THE BOARD COMMITTEE ON FINANCE, AUDIT AND COMPENSATION OF THE ASSOCIATION, PROVIDED THAT PERSONS WITH CONFLICTS OF INTEREST WITH RESPECT TO THE COMPENSATION ARRANGEMENT AT ISSUE ARE NOT INVOLVED IN THIS REVIEW AND APPROVAL. 2. USE OF DATA AS TO COMPARABLE COMPENSATION: THE COMPENSATION OF THE PERSON IS REVIEWED AND APPROVED USING DATA AS TO COMPARABLE COMPENSATION FOR SIMILARLY QUALIFIED PERSONS IN FUNCTIONALLY COMPARABLE POSITIONS AT SIMILARLY SITUATED ORGANIZATIONS. 3. CONTEMPORANEOUS DOCUMENTATION AND RECORDKEEPING: THERE IS CONTEMPORANEOUS DOCUMENTATION AND RECORDKEEPING WITH RESPECT TO THE DELIBERATIONS AND DECISIONS REGARDING THE COMPENSATION ARRANGEMENT. FORM 990, PART VI, SECTION C, LINE 19 FINANCIAL STATEMENTS, CONFLICT OF INTEREST POLICY AND GOVERNING DOCUMENTS ARE AVAILABLE UPON REQUEST FOR THE SAME PERIOD OF DISCLOSURE AS SET FORTH IN SECTION 6104(D). FORM 990, PART IX, LINE 11G OTHER CONSULTING EXPENSE 3,978,805. FORM 990, PART XI, LINE 9: CHANGE IN EQUITY IN ADVAMED PURCHASING GROUP -277,945. ADVANCED MEDICAL TECHNOLOGY ASSOCIATION POLITICAL ACTION COMMITTEE 701 PENNSYLVANIA AVENUE NW SUITE 80 WASHINGTON DC 20004 522134566 POLITICAL ACTION COMMITTEE DC 527 ADVANCED MEDICAL TECHNOLOGY ASSOCIATION 1 ADVANCED MEDICAL TECHNOLOGY ASSOCIATION CA PAC 701 PENNSYLVANIA AVENUE NW SUITE 80 WASHINGTON DC 20004 455309081 POLITICAL ACTION COMMITTEE DC 527 ADVANCED MEDICAL TECHNOLOGY ASSOCIATION 1 MEDTECH CONFERENCE PARTNERS LLC 701 PENNSYLVANIA AVENUE NW SUITE 80 WASHINGTON DC 20004 364725626 TRADE SHOW DC ADVANCED MEDICAL TECHNOLOGY ASSOCIATION RELATED 577631 752372 1 1 0.50000 ADVAMED PURCHASING GROUP INC 701 PENNSYLVANIA AVENUE NW SUITE 80 WASHINGTON DC 20004 812764022 GROUP PURCHASING PROGRAM DC ADVANCED MEDICAL TECHNOLOGY ASSOCIATION C 1.00000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 1 0 1 MEDTECH CONFERENCE PARTNERS LLC S 277363 CASH